Current Treatment and Outcomes Benchmark for Locally Advanced or Metastatic Urothelial Cancer From a Large UK-Based Single Centre

Current Treatment and Outcomes Benchmark for Locally Advanced or Metastatic Urothelial Cancer From a Large UK-Based Single Centre

Objectives: To characterize treatment patterns and survival outcomes for patients with locally advanced or metastatic malignancy of the urothelial tract during a period immediately preceding the widespread use of immune checkpoint inhibitors in the UK.Patients and Methods: We retrospectively examine...

Full description

Bibliographic Details
Main Authors: Sue Cheeseman, Matthew Thompson, Will Sopwith, Paul Godden, Divyagiri Seshagiri, Lola Adedokun, Kieran Zucker, Sunjay Jain, Sanjeev Kotwal, Stephen Prescott, Ann Henry, Joji Joseph, Sameer Chilka, Jo-An Roulson, Michael Weston, Simon Burbidge, Simon Brown, Satinder Jagdev, Christy Ralph, Geoff Hall, Naveen S. Vasudev
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-02-01
Series:Frontiers in Oncology
Subjects:
carboplatin
cisplatin
real-world
chemotherapy
urothelial cancer
Online Access:https://www.frontiersin.org/article/10.3389/fonc.2020.00167/full

Internet

https://www.frontiersin.org/article/10.3389/fonc.2020.00167/full

Similar Items